Signet Financial Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-77
Closed -$36K 1353
2021
Q4
$36K Buy
+77
New +$33.1K 0.01% 624

Other funds holding WST

Signet Financial Management's WST Position: Q1 2022 in Review

Signet Financial Management sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 77 shares — an estimated $36K sold.

Signet Financial Management first reported a position in WST in Q4 2021 and held it in 1 quarter. The position peaked at $36K in Q4 2021. 717 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • Signet Financial Management reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Signet Financial Management sold 77 West Pharmaceutical shares in Q1 2022, an estimated $36K.
  • Signet Financial Management first reported a position in West Pharmaceutical in Q4 2021 and held it in 1 quarter.
  • Signet Financial Management's West Pharmaceutical position peaked at $36K in Q4 2021.
  • 717 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on Signet Financial Management's 13F filing for Q1 2022, filed 13 May 2022.